(BUSINESS WIRE)--BioVex Inc, a company developing next generation biologics for the treatment and prevention of cancer and infectious disease, announces today that its CEO, Philip Astley-Sparke will present at the 29th Annual J.P Morgan Healthcare Conference in San Francisco on Wednesday 12th January at 4:00 PM PST.
